Dimensions: 4761 x 7142 px | 40.3 x 60.5 cm | 15.9 x 23.8 inches | 300dpi Date taken: 7 February 2026 Location: Vadnais Heights, Minnesota, USA More information: Photo Illustration of the new Wegovy 1.5 and 4 mg semaglutide tablets with injectable prescription weight loss medicines, Ozempic, and Victoza
Batch-specific COA (Certificate of Analysis) provided upon request
Semaglutide binds to GLP-1 receptors in the brain, pancreas, and gastrointestinal tract
Better Blood Sugar Control Originally developed for managing type 2 diabetes, GLP-1 medications help regulate blood sugar by improving insulin sensitivity and reducing blood sugar spikes
This sparked interest in understanding and exploiting their health benefits
In the official clinical guidelines of the American Thoracic Society for the role of weight management in the treatment of adults with OSA it was stated that individuals with BMI 27 kg/m 2 (in whom body weight has not been improved despite lifestyle modifications) can be evaluated for anti-obesity pharmacotherapy, although currently there is insufficient evidence to recommend any pharmacotherapy [31, 32]
